<- Go Home
Medtronic MiniMed, Inc.
Medtronic MiniMed, Inc. designs, manufactures, and markets products for diabetic patients and medical professionals in the United States and internationally. Its products include insulin pump systems that includes MiniMed 770G system and MiniMed 630G system, continuous glucose monitoring (CGM) that include Guardian connect system, smart insulin pen that include InPen smart insulin pen, injection port that include i-Port Advance injection port, and therapy management that include CareLink software. The company also serves customers online. Medtronic MiniMed, Inc. was formerly known as MiniMed, Inc. and changed its name to Medtronic MiniMed, Inc. in August 2001. Medtronic MiniMed, Inc. was incorporated in 1993 and is based in Northridge, California. Medtronic MiniMed, Inc. operates as a subsidiary of Medtronic plc.
Market Cap
$3.1B
Volume
1.0M
Cash and Equivalents
$65.9M
EBITDA
$57.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$229.6M
Profit Margin
67.33%
52 Week High
$92.56
52 Week Low
$25.00
Dividend
N/A
Price / Book Value
7.05
Price / Earnings
76.19
Price / Tangible Book Value
7.05
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$43.0M
Return on Equity
10.44%
Return on Assets
6.15
Cash and Short Term Investments
$134.5M
Debt
N/A
Equity
$441.0M
Revenue
$341.0M
Unlevered FCF
-$54.8M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium